loader image
Sunday, November 23, 2025
76.4 F
McAllen
- Advertisement -

CDC Activates Emergency Operations Center for Monkeypox Response

Translate to Spanish or other 102 languages!

 This action stands up the CDC’s command center for monitoring and coordinating the emergency response to monkeypox and mobilizing additional CDC personnel and resources.  Image for illustration purposes
This action stands up the CDC’s command center for monitoring and coordinating the emergency response to monkeypox and mobilizing additional CDC personnel and resources.  Image for illustration purposes

Mega Doctor News

- Advertisement -

The CDC continues to lean forward with an aggressive public health response to the monkeypox outbreak by activating its Emergency Operations Center (EOC). This action stands up the CDC’s command center for monitoring and coordinating the emergency response to monkeypox and mobilizing additional CDC personnel and resources.  CDC’s activation of the EOC allows the agency to further increase operational support for the response to meet the outbreak’s evolving challenges. It is home to more than 300 CDC staff working in collaboration with local, national, and international response partners on public health challenges. The activation of the EOC will serve to further supplement the ongoing work of CDC staff to respond to this outbreak.

Globally, early data suggest that gay, bisexual, and other men who have sex with men make up a high number of monkeypox cases. CDC continues to provide guidance and raise awareness among frontline healthcare providers and public health. CDC is also raising awareness of the current situation with the public through its website and social media in addition to direct partner and community outreach.

In June, CDC updated and expanded the monkeypox case definition and continues to encourage health care providers to consider testing for all rashes with clinical suspicion for monkeypox. Health care providers who see a patient with a rash that resembles monkeypox or might be more characteristic of more common infections (e.g., varicella zoster, herpes zoster, or syphilis) should carefully evaluate the patient for monkeypox and should consider testing.  Anyone who has risk factors for monkeypox, and a new rash should seek care and testing.

- Advertisement -

Last week, CDC began shipping orthopoxvirus tests to five commercial laboratory companies, including the nation’s largest reference laboratories, to quickly increase monkeypox testing capacity and access in every community. This development will facilitate increased testing, leverage established relationships between clinics, hospitals and commercial laboratories, and support our ability to better understand the scope of the current monkeypox outbreak.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Current Heart Attack Screening Tools Are Not Optimal and Fail to Identify Half the People Who Are at Risk

Current cardiac screening tools used to prevent heart attacks fail to identify nearly half of the people who are actually at risk of having one, according to a new study led by Mount Sinai researchers.

Don’t Overfill Your Plate or Stomach

We’ve all been there: You’re gathered with family or friends for a delicious holiday meal. You start piling food on your plate, and before you know it, there’s no room left – and you haven’t even made it to the cranberry sauce and sweet potatoes.

UT Health San Antonio Center For Brain Health Celebrates with Ribbon Cutting

University of Texas System and UT San Antonio leaders today hailed “a new era of hope, healing and discovery” for neurological patients and their families with a ribbon-cutting for the UT Health San Antonio Center for Brain Health, a $100 million, 103,000-square-foot facility that will bring specialty care, therapy, diagnostics and research under one ro

Rare Mutation that Predicts Strong Immunotherapy Response in Colorectal Cancer Identified

A new study led by researchers at The University of Texas MD Anderson Cancer Center shows that a specific subset of mutations in the POLE gene is strongly associated with durable responses to immunotherapy in patients with metastatic colorectal cancer (CRC).
- Advertisement -
×